Immobilization and controlled release of prostaglandin E2 from poly-L-lactide-co-glycolide microspheres
β Scribed by Christoph Brochhausen; Rolf Zehbe; Bernhard Watzer; Sven Halstenberg; Franziska Gabler; Helmut Schubert; Charles James Kirkpatrick
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 403 KB
- Volume
- 91A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Prostaglandin E~2~ (PGE~2~) is an arachidonic acid metabolite involved in physiological homeostasis and numerous pathophysiological conditions. Furthermore, it has been demonstrated that prostaglandins have a stimulating effect not only on angiogenesis in situ and in vitro but also on chondrocyte proliferation in vitro. Thus, PGE~2~ represents an interesting signaling molecule for various tissue engineering strategies. However, under physiological conditions, PGE~2~ has a halfβlife time of only 10 min, which limits its use in biomedical applications. In the present study, we investigated if the incorporation of PGE~2~ into biodegradable polyβLβlactideβcoβglycolide microspheres results in a prolonged release of this molecule in its active form. PGE~2~βmodified microspheres were produced by a cosolvent emulsification method using CHCl~3~ and HFIP as organic solvents and PVA as emulsifier. Thirteen identical batches were produced; and to each batch 1.0 mL of serumβfree medium was added. The medium was removed at defined time points and then analyzed by gas chromatography tandem mass spectrometry (GC/MS/MS) to measure the residual PGE~2~ content. In this study we demonstrated the prolonged release of PGE~2~, showing a linear increase over the first 12 h, followed by a plateau and a slow decrease. The microspheres were further characterized by scanning electron microscopy. Β© 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
π SIMILAR VOLUMES
In this article, microspheres able to induce the controlled release of oligonucleotide/polyethylenimine complexes are proposed. A model oligonucleotide (the oligothymidilate pdT16) was encapsulated within poly(lactide-co-glycolide) microspheres alone or associated with polyethylenimine (PEI) at diff
Addition of biodegradable polymer shells surrounding polymeric, drugloaded microparticles offers the opportunity to control drug release rates. A novel fabrication method was used to produce microparticles with precise control of particle diameter and the thickness of the polymer shell. The effect o
## Abstract Our laboratory has been developing a completely biodegradable coronary stent which is made of bilayers of biodegradable polyesters. This article presents the preliminary work done to exploit the drug delivery potential of such a polymeric stent. An antiproliferative drug (paclitaxel) wa
The star-shaped poly(lactide-co-glycolide (PLGA)-beta-cyclodextrin (PLGA-beta-CD) copolymer was synthesized by reacting L-lactide, glycolide, and beta-cyclodextrin in the presence of stannous octoate as a catalyst. The structure of PLGA-beta-CD copolymer was confirmed with (1)H-NMR, (13)C-NMR, and F